⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
QNTM News
Quantum Biopharma Ltd. Class B Subordinate Voting Shares
NetworkNewsAudio Announces Audio Press Release (APR) Discussing FDA Clearance for Trial of First-in-Class Treatment Creating ‘Rare Moment’ in MS Research
globenewswire.com
QNTM
Quantum BioPharma Ltd. (NASDAQ: QNTM) Filling Key Gap in MS Treatment, Cleared by FDA to Launch Historic Trials
globenewswire.com
QNTM
Historic First in MS Treatment Could Reshape a Multibillion-Dollar Therapeutics Market
globenewswire.com
QNTM
NVS
MRK
TGTX
BMY
Quantum BioPharma Ltd. NASDAQ: QNTM) Receives FDA Clearance to Begin Trials for Historic MS Treatment
globenewswire.com
QNTM
A Micro-Cap Biotech Just Cleared a Milestone Most Never Reach
globenewswire.com
QNTM
SNY
BIIB
CLNN
Quantum Metric Research Names a Widening Customer Listening Gap as Digital's Next Big Business Problem
globenewswire.com
QNTM
Quantum BioPharma Announces Plans to Voluntarily Delist its Class B Shares from the Canadian Securities Exchange
globenewswire.com
QNTM
Quantum Biopharma Provides Corporate Update
globenewswire.com
QNTM
Global Photonic Quantum Computing Market Report 2026–2036: Evaluating Linear Optics, Continuous Variables, and Strategies of PsiQuantum, Xanadu, Quandela, and ORCA
globenewswire.com
QNTM
Quantum BioPharma Strengthens Equity and Liquidity in Q2 2026 as FDA Approves Lucid-MS for Pivotal Phase 2 Clinical Trial
globenewswire.com
QNTM